NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Forager Raises Take-Private Offer for Repay Holdings to $5.25 Per Share

Repay shares jumped 22% after Forager raised its buyout offer to $5.25 cash, but the deal is still not final.

Forager Raises Take-Private Offer for Repay Holdings to $5.25 Per Share
Credit: Repay Holdings
Already have an account? Sign in.
06/29/2026 · 12:24 PM
RPAY
/ Don’t stop at just one post.

Related↓

Forager Capital Offers $4.80 Cash to Buy Repay Holdings
04/17/2026 · 8:34 AM

Forager Capital Offers $4.80 Cash to Buy Repay Holdings

Forager offers to buy Repay Holdings for $4.80/share in cash, a 75% premium, aiming to take the company private quickly.

/ Subscriber only
/ Read more

Feed↓

Carlisle Makes Multiple Unsolicited Bids for Owens Corning in Potential $10 Billion Deal
Featured/ 06/29/2026 · 1:45 PM

Carlisle Makes Multiple Unsolicited Bids for Owens Corning in Potential $10 Billion Deal

The move could create a major building materials powerhouse amid sector consolidation.

/ Subscriber only
QuidelOrtho Eyes $1.5B Sale of COVID-Era Rapid Testing Business
Featured/ 06/29/2026 · 1:11 PM

QuidelOrtho Eyes $1.5B Sale of COVID-Era Rapid Testing Business

The unit, once a pandemic star, attracts strong private equity interest.

/ Subscriber only
Palisade Bio Stock Surges on Positive FDA Clearance for Next-Gen IBD Therapy
06/29/2026 · 12:48 PM

Palisade Bio Stock Surges on Positive FDA Clearance for Next-Gen IBD Therapy

The FDA has cleared Palisade Bio’s investigational new drug application for PALI-2108. The company will now start its Phase 2 ASCENTRA-UC trial in H2 2026.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe